United States Federal Circuit

ResetAA Font size: Print

Anacor Pharmaceuticals, Inc. v. Iancu, 17-1947

Affirming the decision of the Patent Trial and Appeal Board in an inter partes review proceeding of patents relating to boron-containing small molecules used to treat fungal infections, holding that all of the claims of a patent owned by a company were unpatentable for obviousness.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2018/05/14




  • United States Federal Circuit


FindLaw Career Center

    Select a Job Title

      Post a Job  |  Careers Home

    View More